Bioscience-Medicine news from Texas Public Radio reporters.

Texas Public Radio is supported by contributors to the Bioscience-Medicine News Desk including  Xenex Disinfection Services, the John and Rita Feik Foundation, the John and Susan Kerr Charitable Foundation, the University of Texas Health Science Center at San Antonio, Jean Cheever and San Antonio Technology Center.  Additional support comes from Cappy and Suzy Lawton and InCube Labs.

Texas Biomedical Research Institute

In a move that could strengthen San Antonio’s position as a leader in biomedical research, the Texas Biomedical Research Institute announced an expansion Monday – the design and construction of a new biosafety level four lab.

The world’s deadliest pathogens like Ebola are stored and studied in these facilities. Scientists use them to develop vaccines and therapies.

The new level 4 biosafety lab will be funded with public and private money.

Texas Biomed has the only privately-owned BSL-4 lab in the country.

UT Health San Antonio

When it’s a broken bone or a heart attack, you know to seek emergency medical help. But what about those minor household medical problems like cuts, burns and fevers? In today’s TPR Lifeline, Bioscience-Medicine reporter Wendy Rigby asks internal medicine specialist Fred Campbell, MD, of UT Health San Antonio for some practical advice. Here's a transcript of the interview.

Wendy Rigby / Texas Public Radio

Texas has one of the highest rates of TB in the U.S.  Now, a sweeping effort is underway to diagnose and treat people in South Texas who don’t know they harbor the lung infection.

UT Health San Antonio

The man taking over the helm at the UT Health Cancer Center is coming to San Antonio from the Mayo Clinic in Arizona.

Ruben Mesa, MD, is an oncologist who has served as principal investigator in more than 70 clinical trials. He is an  international expert in a group of bone marrow disorders that often lead to leukemia.

UT Health San Antonio

A San Antonio cancer researcher has won a grant worth more than three million dollars to work in the cutting edge field of immunotherapy.

Tyler Curiel, MD, of UT Health Cancer Center was awarded what’s called a “provocative questions” grant from the National Cancer Institute.